Latest News

What happens when the scores we invent to measure success begin quietly reshaping what we value?

VBR's 0.05% expense ratio and $67.8 billion in assets provide broader diversification across 841 holdings versus IJJ's 303 stocks.

Many spousal beneficiaries have been waiting years to cross this threshold.

Tesla's record quarter looks impressive at first glance, but the numbers beneath it raise a much bigger question about the stock's future. Here's what investors need to know.

Taiwan Semiconductor has its fingerprints all over the modern data center.

Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 13% sequentially from $19.3 million in the first quarter and 18% from $18.4 million a year earlier, as the wound-care company cited growth across its product portfolio and in U.S. and international markets. Presid

The memory maker's earnings keep setting records, and its guidance points to another one. The stock sits about 23% below its high anyway.

Rose Nicole Dominique Reich Sapire exercised stock options and withheld shares to cover tax obligations, retaining 15,246 direct shares and 65,520 options, per her latest Form 4.

AI hardware is becoming harder to manufacture, creating a critical opportunity few investors understand. See which companies could capture the upside and which risks could disrupt the thesis.

Google Cloud is Alphabet's fastest-growing division.

There's good news and bad news.

Earnings season continues to give strong results, but that doesn’t mean each stock is rising because of the news.

Dean's liquidation is on the heels of the stock price climbing nearly 65% over the last 12 months.

Avita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th Annual Boston Growth Conference. Vance, who has been CEO for about 10 months after previously serving

This filing details a non-discretionary tax withholding tied to stock option exercise.

This filing details a non-discretionary sale executed to cover tax withholding from the exercise of vested options.

જેને: જેની ચિંતા હોય.રહેઠાણ એ કોઈ વૈભવી વસ્તુ નથી - તે એક મૂળભૂત અધિકાર છેઇઝરાયલમાં હજારો અપંગ લોકોને દર મહિને એક અશક્ય વાસ્તવિકતાનો સામનો કરવાની ફરજ પડે છ

They are fairly risky, but their potential upside is massive.

The chipmaker's valuation is far higher than those of its peers.

Rani Therapeutics (NASDAQ:RANI) outlined its strategy to expand the use of its RaniPill oral biologic-delivery platform through a mix of technology partnerships, selectively licensed product programs and investments in manufacturing capacity. Chief Executive Officer Talat Imran described the clinic

Nvidia and Meta are attacking artificial intelligence from opposite ends. Discover where each moat is strongest, what could weaken it, and why this battle may produce two winners.

AeroVironment stock is facing a major test as top Wall Street analysts remain divided about its future and bottoming signs emerge

Analog Devices will publish its financial results later this week, with the options market predicting some modest moves.

You pay a price for those extra years of benefits.

This sale reduced an insider's direct equity holdings by 11%.